In February 2016 , Toulouse was at the forefront of the fight against cancer by hosting the Toulouse Onco Week (TOW).
The event taking place in the frame of the World Cancer Day aimed at gathering leading international scientists and major private and public players,actors of research and care .
This widely publicized, event featured promising scientific breakthroughs and the strong involvement of the medico-scientific community. The fight must go on.
« By bringing together scientific, clinical and economic expertise to accelerate research and discovery of personalised therapeutic applications, the Oncopole epitomises Toulouse’s commitment to innovation in the life sciences. The organization of Toulouse Oncoweek 2018 will be the opportunity for the researchers, clinicians, and biotechs to have high-level scientific exchanges in a city which places the excellence and the innovation at the heart of its action. » – Mr Jean-Luc Moudenc, Mayor of Toulouse ; President of Toulouse Metropole.
Scientific programme
February 5, 2018 (9h00-12h00 A.M.) Metastasis and microenvironment – Metabolism
Metastasis & microenvironment
Klaus Pantel (University Medical Center Hamburg-Eppendorf)
Metabolism
Pierre Sonveaux (Université Catholique de Louvain)
Matthew G Vander Heiden (MIT)
Jean-Emmanuel Sarry (Cancer Research Center of Toulouse)
February 5, 2018 (14h00-17h00 P.M.) Genetic instability and DNA damage response
Jan Hoeijmakers (Erasmus University of Rotterdam)
Steve Jackson (University of Cambridge)
Jean-Marc Egly (IGBMC, Strasbourg)
Mark O’Connor (Astra-Zeneca)
Gaëlle Legube (Center for Integrative Biology, Toulouse)
February 6, 2018 (9h00-12h00 A.M.) Epigenetics – Non coding genome and cancer
With the support of 
Epigenetics (including epidemiology)
Maarten van Lohuizen (The Netherlands Cancer Institute)
Non-coding genome & cancer
Ramiro Garzon (The Ohio State University)
Maite Huarte (University of Navarra)
François Payre (Center for Integrative Biology, Toulouse)
February 6, 2018 (14h00-17h00 P.M.) Cancer Immunotherapy, from bench to bed
Jolanda De Vries (Radboud University Nijmegen)
Nathalie Rufer (University of Lausanne)
Jean-Philippe Girard (Institute of Pharmacology and Structural Biology, Toulouse)
February 7, 2018 (9h00-12h00 A.M.) New therapeutic strategies
Combined therapies
Julien Mazières (IUCT-Rangueil Larrey, Cancer Research Center of Toulouse)
Radiotherapy – Proton therapy
Jim Metz (University of Pennsylvania)
Gillies McKenna (University of Oxford)
February 7, 2018 (14h00-17h00 P.M.) Clinical research on Melanoma
Richard Marais (Cancer Research UK Manchester Institute)
Céleste Lebbé (Hôpital Saint-Louis, APHP)
Nicolas Meyer (IUCT-Oncopole, Cancer Research Center of Toulouse)